Translation and validation of the Dutch version of the Fear of Cancer Recurrence Inventory (FCRI-NL)

Helmondt, Sanne Jasperine van; Lee, Marije van der; Vries, Jolanda De

doi:10.1016/j.jpsychores.2017.09.001

Cited by 27 publications

(52 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The primary outcome was FCR, assessed with the severity subscale of the Dutch translation of the Fear of Cancer Recurrence Inventory (FCRI‐SF‐NL), which can be used to screen for clinical levels of FCR . The FCRI‐NL consists of 42 items on a 5‐point Likert scale and comprises seven subscales: triggers, severity (FCRI‐SF‐NL; range 0‐36), psychological distress, coping strategies, functioning impairments, insight, and reassurance .…”

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

No effect of CBT‐based online self‐help training to reduce fear of cancer recurrence: First results of the CAREST multicenter randomized controlled trial

et al. 2019

Self Cite

View full text Add to dashboard Cite

Objective: Fear of cancer recurrence (FCR) is a common consequence of surviving cancer; therefore, easily accessible self-help training could help many cancer survivors deal with FCR at low costs. The CAncer REcurrence Self-help Training (CAREST) trial evaluates the effectiveness of an online-tailored self-help training on the basis of evidence-based cognitive behavioral therapy principles in breast cancer survivors.Also, possible predictors for benefitting from the online self-help training were examined.Methods: This multicenter randomized controlled trial included 262 female breast cancer survivors, randomly assigned to either online self-help training (n = 130) or care as usual (CAU; n = 132). Participants completed questionnaires at baseline (T0), 3 months (T1; after intervention), and 9 months (T2). The primary outcome was FCR (Fear of Cancer Recurrence Inventory Severity subscale). Both effectiveness and predictors were analyzed with latent growth curve modeling (LGCM) according to the intention-to-treat principle. Results:LGCM showed no differences between the average latent slope in both groups (χ 2 1 = .23, P = .63), suggesting that the treatments did not differ in their change in FCR over time. Moreover, no differences were found in the effects of the predictors on the latent slope in both groups (χ 2 1 = .12, P = .73), suggesting that no significant predictors were found for the effect of the intervention on FCR. Conclusion:There was no effect of the CBT-based online self-help training "Less fear after cancer" in the current study. Therefore, we recommend adding professional support to online interventions for FCR.

show abstract

Section: Methodsmentioning

confidence: 99%

“…A cutoff score of 13 or higher (FCRI‐SF‐NL) is considered optimal for detecting the presence of clinically significant FCR . The FCRI‐SF‐NL demonstrated good reliability and validity …”

Section: Methodsmentioning

confidence: 99%

No effect of CBT‐based online self‐help training to reduce fear of cancer recurrence: First results of the CAREST multicenter randomized controlled trial

et al. 2019

Self Cite

View full text Add to dashboard Cite

show abstract

“…The severity, distress and coping subscales will be used to measure FCR severity, distress and coping. The FCRI was translated into Dutch and validated by van Helmondt et al 50. While for the FCRI it is recommended to use the total score of all subscales to obtain a score for FCR,7 this multidimensional structure was not replicated in the validation of the FCRI-NL.…”

Section: Methodsmentioning

confidence: 99%

“…While for the FCRI it is recommended to use the total score of all subscales to obtain a score for FCR,7 this multidimensional structure was not replicated in the validation of the FCRI-NL. Instead, the individual subscales provide important information and are recommended to be used separately 50…”

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

Study protocol of the BLANKET trial: a cluster randomised controlled trial on the (cost-) effectiveness of a primary care intervention for fear of cancer recurrence in cancer survivors

et al. 2019

View full text Add to dashboard Cite

IntroductionMany successfully treated patients with cancer suffer from fear of cancer recurrence (FCR), affecting their quality of life and their physical, emotional, cognitive and social functioning. Effective psychological interventions for FCR exist but are not widely available, as they are typically offered by specialised psycho-oncology professionals and institutes. Concurrently, the role of primary care in cancer and survivorship care is increasing. Therefore, there could be a role for general practitioners (GPs) and mental health workers (MHWs) working in primary care in supporting patients with FCR. In the current study, the effectiveness of a primary care delivered FCR intervention will be evaluated.Methods and analysisA two-armed cluster randomised trial will be conducted. The primary outcome will be FCR severity; secondary outcomes will be FCR-related distress, healthcare uptake and healthcare costs. Primary care practices in the Netherlands will be invited to participate in the study. Participating practices will be stratified by size and socioeconomic status and randomised. In the control arm, practices will provide care as usual. In the intervention arm, practices will offer the cognitive–behavioural FCR intervention that is being studied, which consists of an intake with the GP and five sessions with the MHW. Patients who have finished successful curative treatment for cancer between 3 months and 10 years ago will be invited to participate in the study by invitation letter from their GPs. Participating patients will fill out questionnaires at baseline, after 3 months and after 12 months. Data on healthcare use will be collected from their electronic health records. Qualitative interviews are held at T1 with patients and practitioners in the intervention group.Ethics and disseminationThe Medical Research Ethics Committee (METC) Utrecht has reviewed the study in accordance with the Dutch Medical Research Involving Human Subjects Act (WMO) and other applicable Dutch and European regulations. Based on the requirements of the WMO, the METC Utrecht has issued an approval of the above-mentioned study. Any protocol amendments will be communicated to all relevant parties. Written consent is obtained from study participants. Results will be dispersed through peer-reviewed publications and scientific presentations.Trial registration numberNL7573 in the Netherlands Trial Register on 25-02-2019.

show abstract

Prevalence and clinical and psychological correlates of high fear of cancer recurrence in patients newly diagnosed with head and neck cancer

et al. 2019

View full text Add to dashboard Cite

Background Patients with head and neck cancer (HNC) are vulnerable to fear of cancer recurrence (FCR) and psychiatric morbidity. We investigated the prevalence of high FCR and demographic, clinical, psychological, and psychiatric factors associated with high FCR prior to the start of the treatment. Methods In a cross‐sectional substudy of the large ongoing prospective NET‐QUBIC study questionnaires and psychiatric interviews of 216 patients newly diagnosed with HNC were analyzed. Results High FCR was observed in 52.8% of patients and among those 21.1% also had a lifetime history of selected anxiety or major depressive disorder. FCR was not related to any clinical characteristics; however, younger age, higher anxiety symptoms, introversion, greater needs for support regarding sexuality, and being an exsmoker were significantly associated with higher FCR. Conclusion Factors associated with high FCR provide us with a better conceptual understanding of FCR in patients newly diagnosed with HNC.

show abstract

Translation and validation of the Dutch version of the Fear of Cancer Recurrence Inventory (FCRI-NL)

Cited by 27 publications

References 25 publications

No effect of CBT‐based online self‐help training to reduce fear of cancer recurrence: First results of the CAREST multicenter randomized controlled trial

No effect of CBT‐based online self‐help training to reduce fear of cancer recurrence: First results of the CAREST multicenter randomized controlled trial

Study protocol of the BLANKET trial: a cluster randomised controlled trial on the (cost-) effectiveness of a primary care intervention for fear of cancer recurrence in cancer survivors

Prevalence and clinical and psychological correlates of high fear of cancer recurrence in patients newly diagnosed with head and neck cancer

Contact Info

Product

Resources

About